109 related articles for article (PubMed ID: 707504)
1. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
Scholtz EC; Jaffe JM; Colaizzi JL
Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
[No Abstract] [Full Text] [Related]
2. Relative efficacy and palatability of three activated charcoal mixtures.
Navarro RP; Navarro KR; Krenzelok EP
Vet Hum Toxicol; 1980 Feb; 22(1):6-9. PubMed ID: 7361450
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
[TBL] [Abstract][Full Text] [Related]
4. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
Juhl RP
Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
[TBL] [Abstract][Full Text] [Related]
5. Effect of activated charcoal on aspirin absorption in man. Part I.
Levy G; Tsuchiya T
Clin Pharmacol Ther; 1972; 13(3):317-22. PubMed ID: 5026372
[No Abstract] [Full Text] [Related]
6. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
Levy G; Soda DM; Lampman TA
Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose.
Mayersohn M; Perrier D; Picchioni AL
Clin Toxicol; 1977 Dec; 11(5):561-7. PubMed ID: 608318
[TBL] [Abstract][Full Text] [Related]
8. Effect of gastric pH on antidotal efficacy of activated charcoal in man.
Olkkola KT; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):565-9. PubMed ID: 6511134
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
Curtis RA; Barone J; Giacona N
Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
Easom JM; Caraccio TR; Lovejoy FH
Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
[TBL] [Abstract][Full Text] [Related]
11. Reversible adsorption (desorption) of aspirin from activated charcoal.
Filippone GA; Fish SS; Lacouture PG; Scavone JM; Lovejoy FH
Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
[TBL] [Abstract][Full Text] [Related]
12. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
Neuvonen PJ; Elfving SM; Elonen E
Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
[TBL] [Abstract][Full Text] [Related]
13. Drug adsorption efficacy and palatability of a novel charcoal cookie formulation.
Klein-Schwartz W; Doyon S; Dowling T
Pharmacotherapy; 2010 Sep; 30(9):888-94. PubMed ID: 20795844
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of aspirin absorption by activated charcoal and apomorphine.
Decker WJ; Shpall RA; Corby DG; Combs HF; Payne CE
Clin Pharmacol Ther; 1969; 10(5):710-3. PubMed ID: 5808464
[No Abstract] [Full Text] [Related]
15. Effectiveness of activated charcoal, mineral oil, and castor oil in limiting gastrointestinal absorption of a chlorinated hydrocarbon pesticide.
Morgan DP; Dotson TB; Lin LI
Clin Toxicol; 1977; 11(1):61-70. PubMed ID: 68845
[No Abstract] [Full Text] [Related]
16. Management of acute poisoning with activated charcoal.
Corby DG; Decker WJ
Pediatrics; 1974 Sep; 54(3):324-9. PubMed ID: 4606780
[No Abstract] [Full Text] [Related]
17. Effect of purgatives on antidotal efficacy of oral activated charcoal.
Neuvonen PJ; Olkkola KT
Hum Toxicol; 1986 Jul; 5(4):255-63. PubMed ID: 3733116
[TBL] [Abstract][Full Text] [Related]
18. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
Mathur LK; Jaffe JM; Colaizzi JL; Moriarty RW
Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
[TBL] [Abstract][Full Text] [Related]
19. Improving the palatability of activated charcoal in pediatric patients.
Cheng A; Ratnapalan S
Pediatr Emerg Care; 2007 Jun; 23(6):384-6. PubMed ID: 17572522
[TBL] [Abstract][Full Text] [Related]
20. Innovative approaches to the administration of activated charcoal in pediatric toxic ingestions.
West L
Pediatr Nurs; 1997; 23(6):616-9. PubMed ID: 9429522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
